Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cerebrolysin in Acute Ischemic Stroke Undergoing EVT
NCT05124353Phase 3Unknown
- Sponsor
- Pomeranian Medical University in Szczecin
- Start
- Apr 2021
- Primary completion
- Apr 2023
- Modality
- Native Peptides
- Countries
- 1
01
Overview
A Phase 3 trial of cerebrolysin in ischemic stroke, sponsored by Pomeranian Medical University in Szczecin. Status: unknown.
02
Drugs
cerebrolysin
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT05124353.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05124353.